0001656472-22-000168.txt : 20221110 0001656472-22-000168.hdr.sgml : 20221110 20221110202229 ACCESSION NUMBER: 0001656472-22-000168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221108 FILED AS OF DATE: 20221110 DATE AS OF CHANGE: 20221110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUDYK JAMES DANIEL CENTRAL INDEX KEY: 0001796640 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 221379246 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wf-form4_166812973123654.xml FORM 4 X0306 4 2022-11-08 0 0001656472 Cronos Group Inc. CRON 0001796640 RUDYK JAMES DANIEL 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2G9 ONTARIO, CANADA 1 0 0 0 DEFERRED SHARE UNITS 2022-11-08 4 A 0 53763.44 0 A COMMON SHARES 53763.44 97832.14 D Upon redemption, Deferred Share Units entitle Mr. Rudyk to receive a lump sum cash payment in an amount equal to the fair market value of Company common shares on the date of redemption. Vested Deferred Share Units are mandatorily redeemable by Cronos Group Inc. (the "Company") on the first trading day after Mr. Rudyk ceases to be a director of the Company. Andrew Davisson, as attorney-in-fact 2022-11-11 EX-24 2 ex-24.htm RUDYKPOA2022

Authorization and Designation
to Sign and File
Section 16 Reporting Forms


The undersigned, a director of Cronos Group Inc., a corporation incorporated under the Business Corporations Act (British Columbia) (the "Company"), does hereby authorize and designate Terry Doucet, Andrew Davisson and Aaron Werner, each with right to substitute and resubstitute, but for only so long as each of them is an employee of the Company, to sign and file on his behalf the application for the required Securities and Exchange Commission ("SEC") electronic CIK/CCC codes and any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934 ("Section 16") and Rule 144 under the Securities Act of 1933, as amended.  This authorization, unless earlier revoked in writing, shall be valid until the undersigned's reporting obligations under Section 16 and Rule 144 with respect to equity securities of the Company shall cease.  All prior such authorizations are hereby revoked.

IN WITNESS WHEREOF, the undersigned has executed this Authorization and Designation this 9th day of November, 2022.

/s/ James Rudyk